Appointment booking for Dr. Mary Consevage, MD is currently not available.Dr. Mary Consevage, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Mary Consevage, MD (she/her) is a Pediatrician in Harrisburg, PA with over 18 years of experience. What is your opinion of Dr. Mary Consevage, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mary Consevage, MD has received over $3,684 which includes payments from the following companies:
$681.97 from Pfizer Inc.
$459.75 from Shire North American Group Inc
$397.13 from Tris Pharma Inc
$335.88 from Arbor Pharmaceuticals, Inc.
$318.86 from Sanofi Pasteur Inc.
$245.06 from Neos Therapeutics, LP
$209.59 from Genentech USA, Inc.
$164.88 from Merck Sharp & Dohme Corporation
$115.06 from Kaleo, Inc.
$108.99 from GlaxoSmithKline, LLC.
$91.37 from MedImmune, LLC
$90.04 from Adlon Therapeutics L.P.
$79.46 from Ironshore Pharmaceuticals Inc.
$68.29 from AstraZeneca Pharmaceuticals LP
$61.52 from Mylan Specialty L.P.
$58.31 from Sobi, Inc
$46.22 from Teva Pharmaceuticals USA, Inc.
$45.32 from LILLY USA, LLC
$29.17 from sanofi-aventis U.S. LLC
$28.38 from Noven Pharmaceuticals, Inc.
Payments received by Dr. Mary Consevage, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!